Alpha Teknova (Alpha Teknova) Debt-to-Equity : 0.34 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Alpha Teknova Debt-to-Equity?

Alpha Teknova's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.80 Mil. Alpha Teknova's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $28.66 Mil. Alpha Teknova's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $90.04 Mil. Alpha Teknova's debt to equity for the quarter that ended in Dec. 2023 was 0.34.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Alpha Teknova's Debt-to-Equity or its related term are showing as below:

TKNO' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.21 Max: 0.42
Current: 0.34

During the past 5 years, the highest Debt-to-Equity Ratio of Alpha Teknova was 0.42. The lowest was 0.00. And the median was 0.21.

TKNO's Debt-to-Equity is ranked worse than
53.86% of 856 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs TKNO: 0.34

Alpha Teknova Debt-to-Equity Historical Data

The historical data trend for Alpha Teknova's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Teknova Debt-to-Equity Chart

Alpha Teknova Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

0.08

0.42

0.34

Alpha Teknova Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial												0.42	0.44	0.47	0.31	0.34

Competitive Comparison of Alpha Teknova's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Alpha Teknova's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha Teknova's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpha Teknova's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Alpha Teknova's Debt-to-Equity falls into.

Alpha Teknova Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Alpha Teknova's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.803	+	28.655)	/	90.036
	=	0.34

Alpha Teknova's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.803	+	28.655)	/	90.036
	=	0.34

Alpha Teknova (NAS:TKNO) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Alpha Teknova Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Alpha Teknova's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Teknova (Alpha Teknova) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpha Teknova Inc (NAS:TKNO) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2451 Bert Drive, Hollister, CA, USA, 95023

Website

https://www.teknova.com

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification.

Executives

Ken Gelhaus	officer: Chief Commercial Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Stephen Gunstream	director, officer: See Remarks	2290 BERT DRIVE, HOLLISTER CA 95023
J Matthew Mackowski	director	343 SANSOME ST, SUITE 1215, SANSASAN FRANCISCO CA 94104
Matthew Lowell	officer: Chief Financial Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Damon Terrill	officer: See Remarks	2290 BERT DRIVE, HOLLISTER CA 95023
Thp Iv Affiliates Fund, Llc	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO CA 94108
Martha J Demski	director	7770 REGENTS ROAD SUITE 113-505, SAN DIEGO CA 92122
Lisa Hood	officer: Chief People Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Irene Davis	director	2290 BERT DRIVE, HOLLISTER CA 95023
Ted Davis	director	2290 BERT DRIVE, HOLLISTER CA 95023
Telegraph Hill Partners Iv, L.p.	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO MA 94108
Paul David Grossman	director	1600 FARADAY AVENUE, CARLSBAD CA 92008
Brett Robertson	director	C/O INVUITY, INC., 444 DE HARO STREET, SAN FRANCOSCO CA 94107
Alexander C. Herzick	director	2290 BERT DRIVE, HOLLISTER CA 95023
Telegraph Hill Partners Management Company, Llc	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO CA 94108